COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic Awarded Multi-Year Vaccine Contract by UK Government
02/11/2026
COPENHAGEN, Denmark, November 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has been awarded a new multi-year contract by the UK Government through the UK Health Security Agency (UKHSA) for the [...]
GENFIT présentera ses avancées dans l’ACLF et dans le diagnostic de la MASH lors du congrès AASLD The Liver Meeting® 2026
02/11/2026
ACLF : une stratégie thérapeutique multicibles en développement GENFIT organisera un événement scientifique le 8 novembre 2026 pour présenter sa stratégie dans l’ACLF et le dossier clinique l’ayant conduit à engager [...]
GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026
02/11/2026
ACLF – Advancing a multi-target therapeutic strategy GENFIT to host a scientific event on November 8, 2026 to outline its ACLF strategy and unveil a comprehensive clinical data package supporting the advancement of [...]
Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
02/11/2026
Björn Tackenberg, M.D. Ph.D. FEAN FAAN, Professor of Neurology, will lead Oculis’ global integrated scientific strategy supporting the advancement of Privosegtor and its expansion into new therapeutic applications Aaron [...]
GUERBET : Update on discussions with financial partners.
02/11/2026
Update on discussions with financial partners Villepinte, November 2, 2026, 8.30 A.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces, further to its [...]
GUERBET : Point d’étape sur les discussions avec les partenaires financiers.
02/11/2026
Point d’étape sur les discussions avec les partenaires financiers Villepinte, le 2 novembre 2026, 8h30 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, [...]
Bavarian Nordic – Completion of Share Buy-Back Program
02/11/2026
COPENHAGEN, Denmark, November 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on September 1, 2026, has now been completed, reaching an aggregate [...]
CROSSJECT annonce la mise à disposition du rapport financier semestriel au 30 juin 2026
02/11/2026
DIJON, France CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique internationale spécialisée dans le développement d'auto-injecteurs sans aiguille pour les situations d'urgence, annonce avoir mis à [...]
CROSSJECT annonce la mise à disposition du rapport financier semestriel au 30 juin 2026
02/11/2026
DIJON, France CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique internationale spécialisée dans le développement d'auto-injecteurs sans aiguille pour les situations d'urgence, annonce avoir mis à [...]
Nouscom Strengthens Leadership and Operational Capabilities, Appointing Loredana Siani, Ph.D., as Chief Technology Officer
02/11/2026
Nouscom Strengthens Leadership and Operational Capabilities, Appointing Loredana Siani, Ph.D., as Chief Technology Officer Promotion follows recent €120 million Series D financing as Nouscom advances NOUS-209 into [...]
Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
02/11/2026
Björn Tackenberg, M.D. Ph.D. FEAN FAAN, Professor of Neurology, will lead Oculis’ global integrated scientific strategy supporting the advancement of Privosegtor and its expansion into new therapeutic applications Aaron [...]
Mesoblast Board Changes
02/11/2026
NEW YORK, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced rotational changes and retirement of [...]
HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
02/11/2026
— Follows US FDA new drug application submission in September 2026, marking important global regulatory progress — — Filings supported by positive SAFFRON global Phase III data demonstrating statistically significant [...]
TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
01/11/2026
Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI planning decisions [...]
Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026
01/11/2026
MINNEAPOLIS and BRISBANE, Australia, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global healthcare company committed to designing, [...]
Chaka Khan Opens Chaka's Plantbaed Café in Serenbe, Georgia, November 1
01/11/2026
New plant-based café brings food, music and community together as the Chaka Khan Foundation expands its mission of inclusion through charitable giving and a new playground communication board SERENBE, Ga., Nov. 01, 2026 [...]
Dr. Myung Ju Lee Presents Hybrid Deep Plane Facelift Technique for Nasolabial Fold Correction at ISAPS 2026
31/10/2026
The technique aims to improve correction of pronounced nasolabial folds, a persistent challenge in deep plane facelift surgery CANCÚN, Mexico, Oct. 31, 2026 (GLOBE NEWSWIRE) -- Dr. Myung Ju Lee , founder and medical [...]
Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
30/10/2026
MALVERN, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
SRX Global Provides Update on Balance Sheet and Share Buyback
30/10/2026
NORTH PALM BEACH, Fla., Oct. 30, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum